Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer.
Zheng L, Hu F, Huang L, Lu J, Yang X, Xu J, Wang S, Shen Y, Zhong R, Chu T, Zhang W, Li Y, Zheng X, Han B, Zhong H, Nie W, Zhang X.
Zheng L, et al. Among authors: han b.
J Immunother Cancer. 2024 Apr 18;12(4):e008190. doi: 10.1136/jitc-2023-008190.
J Immunother Cancer. 2024.
PMID: 38641349
Free PMC article.